Table 3.
n | 5 years | 10 years | 20 years | ||||
---|---|---|---|---|---|---|---|
OS (%) | BCSS (%) | OS (%) | BCSS (%) | OS (%) | BCSS (%) | ||
Cumulative survival rates depending on molecular subtype | |||||||
All | 445 | 94 | 98 | 84 | 96 | 60 | 89 |
LumA | 209 | 95 | 98 | 85 | 97 | 60 | 91 |
LumB | 180 | 94 | 97 | 83 | 96 | 59 | 83 |
TNBC | 30 | 87 | 89 | 70 | 85 | 53 | 85 |
HER2+ | 26 | 96 | 100 | 88 | 91 | 68 | 91 |
OS overall survival, BCSS breast cancer specific survival, LumA Luminal A-like, LumB Luminal B-like (HER2−), TNBC triple negative breast cancer, HER2+ HER2-positive